NO924166L - Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav - Google Patents
Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling deravInfo
- Publication number
- NO924166L NO924166L NO92924166A NO924166A NO924166L NO 924166 L NO924166 L NO 924166L NO 92924166 A NO92924166 A NO 92924166A NO 924166 A NO924166 A NO 924166A NO 924166 L NO924166 L NO 924166L
- Authority
- NO
- Norway
- Prior art keywords
- radical
- substituted
- phenyl
- alkyl
- radicals
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Cosmetics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Det er beskrevet farmakologisk virksomme forbindelser med generell formel (D X-R hvor X betyr oksygen eller svovel og resten R betyr en klnuklldylrest, en C1-C6-alkylrest, en fenfølrest, en pyrldylrest, en med restene R! , R2 og/eller B3 substituert fenyl- eller pyrldylrest, en med pyrldyl eller alkylpyrldyl substituert C1-C6-alklylrest, eller en med fenyl substituert Ci-C^-alkylrest, hvorved hver fenylrest også kan være substituert med restene Ri, R2 og/eller R3 og restene R! , R2 og R3 er Ilke eller forskjellige og betyr hydrogen, halogen, trlhalogen- metyl, C1-C6-alkyl, C1-C6-alkoksy, karboksy, karb-Cj- C6-alkoksy, amlno, C1-C6-alkylamino, C1-C6-dlalkyl- amlno, Cj-Cfc-trialkylamino, C2-C6-alkanoylamino eller C2-C6-alkanoylamino, som l alkyldelen også Inneholder en amlnogruppe og deres fysiologisk godtagbare syreaddisjonssalter.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4135910 | 1991-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO924166D0 NO924166D0 (no) | 1992-10-29 |
| NO924166L true NO924166L (no) | 1993-05-03 |
Family
ID=6443832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92924166A NO924166L (no) | 1991-10-31 | 1992-10-29 | Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5354750A (no) |
| EP (1) | EP0539805B1 (no) |
| JP (1) | JPH05222002A (no) |
| KR (1) | KR930007914A (no) |
| CN (1) | CN1071916A (no) |
| AT (1) | ATE157656T1 (no) |
| AU (1) | AU660726B2 (no) |
| BR (1) | BR9204187A (no) |
| CA (1) | CA2081819A1 (no) |
| DE (2) | DE4234933A1 (no) |
| DK (1) | DK0539805T3 (no) |
| ES (1) | ES2108066T3 (no) |
| FI (1) | FI924934A (no) |
| GR (1) | GR3025141T3 (no) |
| HU (2) | HUT62866A (no) |
| IL (1) | IL103601A0 (no) |
| MX (1) | MX9206245A (no) |
| NO (1) | NO924166L (no) |
| TW (1) | TW211563B (no) |
| ZA (1) | ZA928420B (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9226573D0 (en) * | 1992-12-21 | 1993-02-17 | Ici Plc | Heterocyclic compounds |
| US6514983B1 (en) | 1997-09-03 | 2003-02-04 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating neural or cardiovascular tissue damage |
| US6346536B1 (en) | 1997-09-03 | 2002-02-12 | Guilford Pharmaceuticals Inc. | Poly(ADP-ribose) polymerase inhibitors and method for treating neural or cardiovascular tissue damage using the same |
| US6291425B1 (en) | 1999-09-01 | 2001-09-18 | Guilford Pharmaceuticals Inc. | Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| US6426415B1 (en) | 1997-09-03 | 2002-07-30 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods and compositions for inhibiting parp activity |
| US6197785B1 (en) * | 1997-09-03 | 2001-03-06 | Guilford Pharmaceuticals Inc. | Alkoxy-substituted compounds, methods, and compositions for inhibiting PARP activity |
| US20020028813A1 (en) * | 1997-09-03 | 2002-03-07 | Paul F. Jackson | Thioalkyl compounds, methods, and compositions for inhibiting parp activity |
| US6635642B1 (en) | 1997-09-03 | 2003-10-21 | Guilford Pharmaceuticals Inc. | PARP inhibitors, pharmaceutical compositions comprising same, and methods of using same |
| US6395749B1 (en) | 1998-05-15 | 2002-05-28 | Guilford Pharmaceuticals Inc. | Carboxamide compounds, methods, and compositions for inhibiting PARP activity |
| US6387902B1 (en) | 1998-12-31 | 2002-05-14 | Guilford Pharmaceuticals, Inc. | Phenazine compounds, methods and pharmaceutical compositions for inhibiting PARP |
| WO2001090077A1 (en) | 2000-05-19 | 2001-11-29 | Guilford Pharmaceuticals, Inc. | Sulfonamide and carbamide derivatives of 6(5h)phenanthridinones and their uses |
| AU2002220241A1 (en) * | 2000-12-01 | 2002-06-11 | Iconix Pharmaceuticals, Inc. | Parb inhibitors |
| GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2484029A (en) * | 1945-12-21 | 1949-10-11 | Ciba Pharm Prod Inc | Hydrazine derivatives of pyridazine compounds |
| US3882119A (en) * | 1970-01-27 | 1975-05-06 | Lepetit Spa | Tetracyclic substituted phthalazine compounds |
| IL48319A0 (en) * | 1974-10-26 | 1975-12-31 | Merck Patent Gmbh | Araliphatic nitrogen compounds and a process for their preparation |
| JPH01261386A (ja) * | 1988-04-11 | 1989-10-18 | Nisshin Flour Milling Co Ltd | 新規な２―ピリジルメチルチオ誘導体及びそれを含有する抗潰瘍剤 |
-
1992
- 1992-10-16 AT AT92117672T patent/ATE157656T1/de not_active IP Right Cessation
- 1992-10-16 DE DE4234933A patent/DE4234933A1/de not_active Withdrawn
- 1992-10-16 DK DK92117672.3T patent/DK0539805T3/da active
- 1992-10-16 DE DE59208852T patent/DE59208852D1/de not_active Expired - Fee Related
- 1992-10-16 ES ES92117672T patent/ES2108066T3/es not_active Expired - Lifetime
- 1992-10-16 EP EP92117672A patent/EP0539805B1/de not_active Expired - Lifetime
- 1992-10-20 US US07/963,631 patent/US5354750A/en not_active Expired - Fee Related
- 1992-10-28 BR BR929204187A patent/BR9204187A/pt not_active Application Discontinuation
- 1992-10-28 JP JP4290058A patent/JPH05222002A/ja active Pending
- 1992-10-29 MX MX9206245A patent/MX9206245A/es unknown
- 1992-10-29 NO NO92924166A patent/NO924166L/no unknown
- 1992-10-30 FI FI924934A patent/FI924934A/fi not_active Application Discontinuation
- 1992-10-30 CN CN92112607A patent/CN1071916A/zh not_active Withdrawn
- 1992-10-30 KR KR1019920020137A patent/KR930007914A/ko not_active Application Discontinuation
- 1992-10-30 IL IL103601A patent/IL103601A0/xx unknown
- 1992-10-30 AU AU27471/92A patent/AU660726B2/en not_active Ceased
- 1992-10-30 HU HU9203431A patent/HUT62866A/hu unknown
- 1992-10-30 CA CA002081819A patent/CA2081819A1/en not_active Abandoned
- 1992-10-30 ZA ZA928420A patent/ZA928420B/xx unknown
- 1992-12-02 TW TW081109717A patent/TW211563B/zh active
-
1995
- 1995-06-29 HU HU95P/P00584P patent/HU211863A9/hu unknown
-
1997
- 1997-10-22 GR GR970402773T patent/GR3025141T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO924166D0 (no) | 1992-10-29 |
| CA2081819A1 (en) | 1993-05-01 |
| CN1071916A (zh) | 1993-05-12 |
| FI924934A0 (fi) | 1992-10-30 |
| BR9204187A (pt) | 1993-05-04 |
| DK0539805T3 (da) | 1998-03-23 |
| FI924934A (fi) | 1993-05-01 |
| JPH05222002A (ja) | 1993-08-31 |
| HUT62866A (en) | 1993-06-28 |
| ZA928420B (en) | 1993-05-14 |
| MX9206245A (es) | 1993-05-01 |
| IL103601A0 (en) | 1993-03-15 |
| US5354750A (en) | 1994-10-11 |
| GR3025141T3 (en) | 1998-02-27 |
| HU9203431D0 (en) | 1993-01-28 |
| DE59208852D1 (de) | 1997-10-09 |
| ES2108066T3 (es) | 1997-12-16 |
| DE4234933A1 (de) | 1993-05-06 |
| EP0539805A1 (de) | 1993-05-05 |
| ATE157656T1 (de) | 1997-09-15 |
| KR930007914A (ko) | 1993-05-20 |
| EP0539805B1 (de) | 1997-09-03 |
| AU2747192A (en) | 1993-05-06 |
| AU660726B2 (en) | 1995-07-06 |
| HU211863A9 (en) | 1995-12-28 |
| TW211563B (no) | 1993-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO924166L (no) | Nye ftalaziner som i 1-stilling inneholder en eter- ellertioetergruppe og fremgangsmaate for fremstilling derav | |
| DE69406649T2 (de) | N-alkyl-2-substituierte atp-analoge | |
| MY107756A (en) | Piperazine derivatives. | |
| SE8503888D0 (sv) | Heterocykliska derivat | |
| DK0580502T3 (da) | 3-(hydroxybenzylidenyl)-indolin-2-oner og farmaceutiske sammensætninger indeholdende disse | |
| NO166129C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-9h-pyrido (3,4-b)indoler. | |
| LU90758I2 (fr) | Almotriptan et ses sels pharmaceutiquement acceptables | |
| EP0529452A3 (de) | 1,7-anellierte 2-(Piperazino-alkyl)indol-Derivate sowie Verfahren und Zwischenprodukte zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| FI101301B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi | |
| IS1746B (is) | Hliðstæð aðferð til tilreiðslu á nýjum afleiðum thiazolidinone og oxazolidinone sem gagnlegar eru til æðaútvíkkunar | |
| NO162234C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinkarboksylsyreestere. | |
| HUT37797A (en) | Process for production of tetrahydro-tieno-piridinderivatives and medical preparatives containing of such compounds | |
| NO982927L (no) | Biologisk aktive benzotiazolon etanaminer | |
| DK0387489T3 (da) | Anvendelse af 2,2,6,6-tetramethyl-4-aminopiperidinamider som fungicider | |
| DK432086D0 (da) | Fremgangsmaade til fremstilling af beta-lactamforbindelser eller saltederaf | |
| FI894125A (fi) | Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi | |
| DK0573360T3 (da) | Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister |